What is HepatoChem?
HepatoChem, Inc. is a prominent manufacturer specializing in photochemistry reactors, LEDs, and associated accessories. The company's flagship product, the PhotoRedOx Box, has garnered significant recognition within the scientific community, evidenced by its citation in numerous peer-reviewed research papers. This photoreactor is highly valued for its consistent reproducibility of reaction results and its capability to fully irradiate photochemical samples. HepatoChem has broadened its product line to include the PhotoRedOx Duo, offering double the capacity of the original design, and the PhotoRedOx Box TC, which facilitates photochemistry experiments at controlled temperatures ranging from 0 to 80 degrees Celsius. This focus on precision and expanded functionality positions HepatoChem as a key player in enabling cutting-edge photochemical research and development.
How much funding has HepatoChem raised?
HepatoChem has raised a total of $61K across 1 funding round:
Debt
$61K
Debt (2021): $61K with participation from PPP
What's next for HepatoChem?
The recent capital injection, occurring at a significant Series B/C stage, signals HepatoChem's intent to scale its operations and potentially enhance its manufacturing capabilities or expand its market reach. This strategic financing is likely to fuel further innovation in their photochemistry reactor technology, possibly leading to the development of new product lines or improvements to existing ones. The company's established reputation for quality and reproducibility in scientific equipment suggests a strong foundation for future growth and market penetration, aiming to solidify its leadership in specialized photochemical instrumentation.
See full HepatoChem company page
